The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The price of Abbvie Inc (NYSE: ABBV) closed at $160.45 in the last session, down -1.29% from day before closing price of $162.55. In other words, the price has decreased by -$1.29 from its previous closing price. On the day, 5.8 million shares were traded. ABBV stock price reached its highest trading level at $162.9 during the session, while it also had its lowest trading level at $159.87.
Ratios:
We take a closer look at ABBV’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 15.68 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 12.97. For the most recent quarter (mrq), Quick Ratio is recorded 0.83 and its Current Ratio is at 0.94. In the meantime, Its Debt-to-Equity ratio is 9.24 whereas as Long-Term Debt/Eq ratio is at 7.97.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Mar 20 ’24 when Donoghoe Nicholas sold 21,082 shares for $176.30 per share. The transaction valued at 3,716,757 led to the insider holds 55,903 shares of the business.
Stewart Jeffrey Ryan sold 58,949 shares of ABBV for $10,539,508 on Mar 18 ’24. The EVP, CHIEF COMMERCIAL OFFICER now owns 60,941 shares after completing the transaction at $178.79 per share. On Mar 01 ’24, another insider, RICHMOND TIMOTHY J., who serves as the EVP, CHIEF HR OFFICER of the company, sold 75,680 shares for $177.27 each. As a result, the insider received 13,415,503 and left with 13,837 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ABBV now has a Market Capitalization of 283333820416 and an Enterprise Value of 343371808768. As of this moment, Abbvie’s Price-to-Earnings (P/E) ratio for their current fiscal year is 47.77, and their Forward P/E ratio for the next fiscal year is 13.32. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 7.84. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.21 while its Price-to-Book (P/B) ratio in mrq is 35.38. Its current Enterprise Value per Revenue stands at 6.312 whereas that against EBITDA is 13.381.
Stock Price History:
Over the past 52 weeks, ABBV has reached a high of $182.89, while it has fallen to a 52-week low of $130.96. The 50-Day Moving Average of the stock is -6.95%, while the 200-Day Moving Average is calculated to be 1.76%.
Shares Statistics:
According to the various share statistics, ABBV traded on average about 5.69M shares per day over the past 3-months and 6007020 shares per day over the past 10 days. A total of 1.77B shares are outstanding, with a floating share count of 1.76B. Insiders hold about 0.12% of the company’s shares, while institutions hold 71.76% stake in the company. Shares short for ABBV as of 1713139200 were 13536080 with a Short Ratio of 2.38, compared to 1710460800 on 14691308. Therefore, it implies a Short% of Shares Outstanding of 13536080 and a Short% of Float of 0.77.
Dividends & Splits
The forward annual dividend rate for ABBV is 6.06, which was 6.06 in the trailing 12 months. Against a Trailing Annual Dividend Yield of 0.037280835The stock’s 5-year Average Dividend Yield is 4.4.
